Abstract
After modification, a technique for radiometrically measuring bacterial growth has been applied to a mutant strain of Saccharomyces cerevisiae. The assay is based on inhibition of 14CO2 release from [14C]glucose, which provides an extremely sensitive measure of cellular respiratory activity and growth. The criterion for antitumor activity is the differential inhibition of wild-type and mutant (distorted cell membrane) strains of the yeast. The system was optimized for medium, time of incubation, temperature, and size of inoculum. Known antitumor agents, including bleomycin, actinomycin D, adriamycin, and ellipticine were tested in the system, and differential inhibition was observed. Vincristine showed no inhibitory effects at the concentrations tried. The sensitivity for 20% inhibition ranged from 0.8 micrograms of adriamycin per ml to 0.14 mg of ellipticine per ml. Antifungal agents such as amphotericin B exhibited no differential inhibition. Antibacterial agents were inactive. This method may provide a rapid, sensitive, in vitro quantitative assay for antitumor agents which could be applied to a variety of assay needs and which can be run with facilities and equipment available in most laboratories.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bradner W. T. Bristol Laboratories Division, Bristol-Myers Company, Syracuse, N.Y. Antibiot Chemother (1971) 1978;23:4–11. [PubMed] [Google Scholar]
- Buddemeyer E. U. Liquid scintillation vial for cumulative and continuous radiometric measurement of in vitro metabolism. Appl Microbiol. 1974 Aug;28(2):177–180. doi: 10.1128/am.28.2.177-180.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gause G. F., Laiko A. V., Selesneva T. I. Yeast mutants with distorted cell membranes as tests in the screening for antitumor antibiotics. Cancer Treat Rep. 1976 May;60(5):637–638. [PubMed] [Google Scholar]